Literature DB >> 2851097

Characterization of the transposon carrying the STII gene of enterotoxigenic Escherichia coli.

S T Hu1, C H Lee.   

Abstract

The Escherichia coli enterotoxin STII gene is carried by Tn4521. The terminal repeats of Tn4521 are composed of IS2 sequences; however, neither repeat is a complete IS2. In order to determine how this seemingly defective transposon could transpose, mutations were generated within Tn4521 to determine the regions essential for transposition. The left terminal repeat region was found to be non-essential, but the right terminal repeat area was demonstrated to be crucial for transposition. Within the right terminal repeat area is an open reading frame (ORF), capable of encoding a 159 amino acid protein, which was shown by frameshift mutation analysis to be required for transposition. This protein may be the transposase of Tn4521. A pair of 11 bp repeat sequences flanking the ORF was also pair of 11 bp repeat sequences flanking the ORF was also found to be important. The right 11 bp repeat is part of the left IS2 terminal sequence, and the left 11 bp repeat is located about 300 bp upstream from the right IS2 terminal sequence located within the right terminal repeat region. The results of this study suggest that Tn4521 is a functional transposon and that the sequence including this pair of 11 bp sequences plus the intervening sequence is a transposable element which may be responsible for Tn4521 transposition.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2851097     DOI: 10.1007/bf00330485

Source DB:  PubMed          Journal:  Mol Gen Genet        ISSN: 0026-8925


  23 in total

1.  Human diarrheal disease caused by enterotoxigenic Escherichia coli.

Authors:  R B Sack
Journal:  Annu Rev Microbiol       Date:  1975       Impact factor: 15.500

2.  Isolation of a novel transposon which carries the Escherichia coli enterotoxin STII gene.

Authors:  C H Lee; S T Hu; P J Swiatek; S L Moseley; S D Allen; M So
Journal:  J Bacteriol       Date:  1985-05       Impact factor: 3.490

3.  Immunological cross-reactivity between a heat-labile enterotoxin(s) of Escherichia coli and subunits of Vibrio cholerae enterotoxin.

Authors:  J D Clements; R A Finkelstein
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

4.  Plasmid-associated enterotoxin production in a strain of Escherichia coli isolated from humans.

Authors:  F J Skerman; S B Formal; S Falkow
Journal:  Infect Immun       Date:  1972-04       Impact factor: 3.441

5.  A complementation analysis of the restriction and modification of DNA in Escherichia coli.

Authors:  H W Boyer; D Roulland-Dussoix
Journal:  J Mol Biol       Date:  1969-05-14       Impact factor: 5.469

6.  Biological evaluation of a methanol-soluble, heat-stable Escherichia coli enterotoxin in infant mice, pigs, rabbits, and calves.

Authors:  M N Burgess; R J Bywater; C M Cowley; N A Mullan; P M Newsome
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

7.  Test for Escherichia coli enterotoxin using infant mice: application in a study of diarrhea in children in Honolulu.

Authors:  A G Dean; Y C Ching; R G Williams; L B Harden
Journal:  J Infect Dis       Date:  1972-04       Impact factor: 5.226

8.  Immunological study of the heat-labile enterotoxins of Escherichia coli and Vibrio cholerae.

Authors:  C L Gyles
Journal:  Infect Immun       Date:  1974-03       Impact factor: 3.441

9.  Studies on transformation of Escherichia coli with plasmids.

Authors:  D Hanahan
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

10.  A bovine papilloma virus vector with a dominant resistance marker replicates extrachromosomally in mouse and E. coli cells.

Authors:  P D Matthias; H U Bernard; A Scott; G Brady; T Hashimoto-Gotoh; G Schütz
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  10 in total

Review 1.  Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance.

Authors:  José L Martínez; Fernando Baquero
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

2.  Isolation and molecular characterization of spontaneously occurring cytolysin-negative mutants of Actinobacillus pleuropneumoniae serotype 7.

Authors:  C Anderson; A A Potter; G F Gerlach
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

3.  Detection of an IS2-encoded 46-kilodalton protein capable of binding terminal repeats of IS2.

Authors:  S T Hu; L C Lee; G S Lei
Journal:  J Bacteriol       Date:  1996-10       Impact factor: 3.490

Review 4.  Insertion sequences.

Authors:  J Mahillon; M Chandler
Journal:  Microbiol Mol Biol Rev       Date:  1998-09       Impact factor: 11.056

5.  Functional domains of the InsA protein of IS2.

Authors:  G S Lei; S T Hu
Journal:  J Bacteriol       Date:  1997-10       Impact factor: 3.490

Review 6.  Animal Enterotoxigenic Escherichia coli.

Authors:  J Daniel Dubreuil; Richard E Isaacson; Dieter M Schifferli
Journal:  EcoSal Plus       Date:  2016-10

7.  Negative regulation of IS2 transposition by the cyclic AMP (cAMP)-cAMP receptor protein complex.

Authors:  S T Hu; H C Wang; G S Lei; S H Wang
Journal:  J Bacteriol       Date:  1998-05       Impact factor: 3.490

8.  Effects of selection pressure and genetic association on the relationship between antibiotic resistance and virulence in Escherichia coli.

Authors:  Lixin Zhang; Karen Levy; Gabriel Trueba; William Cevallos; James Trostle; Betsy Foxman; Carl F Marrs; Joseph N S Eisenberg
Journal:  Antimicrob Agents Chemother       Date:  2015-08-17       Impact factor: 5.191

9.  A novel transposon-like structure carries the genes for pyocin AP41, a Pseudomonas aeruginosa bacteriocin with a DNase domain homology to E2 group colicins.

Authors:  Y Sano; M Kageyama
Journal:  Mol Gen Genet       Date:  1993-02

10.  Two amino acid residues of transposase contributing to differential transposability of IS1 elements in Escherichia coli.

Authors:  J H Chen; W B Hsu; J L Hwang
Journal:  J Bacteriol       Date:  1998-10       Impact factor: 3.490

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.